Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000213023 | SCV000171891 | benign | not specified | 2013-12-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000128299 | SCV000214189 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000473797 | SCV000554115 | likely benign | Peutz-Jeghers syndrome | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000128299 | SCV000686700 | likely benign | Hereditary cancer-predisposing syndrome | 2017-03-08 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000213023 | SCV002046997 | likely benign | not specified | 2021-04-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000473797 | SCV002057443 | likely benign | Peutz-Jeghers syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000128299 | SCV002526955 | likely benign | Hereditary cancer-predisposing syndrome | 2021-08-19 | criteria provided, single submitter | curation | |
Prevention |
RCV003905222 | SCV004721838 | likely benign | STK11-related disorder | 2024-03-02 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
All of Us Research Program, |
RCV000473797 | SCV004818931 | likely benign | Peutz-Jeghers syndrome | 2023-08-28 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001357918 | SCV001553519 | likely benign | Malignant tumor of breast | no assertion criteria provided | clinical testing | The STK11 p.Pro294= variant was not identified in the literature nor was it identified in the MutDB, LOVD 3.0, Zhejiang Colon Cancer Database, Insight Hereditary Tumors Database. The variant was identified in dbSNP (ID: rs587781178) “With Likely benign allele,” ClinVar (as benign by GeneDx and likely benign by Ambry Genetics and Invitae), Clinvitae, and Cosmic databases. The variant was identified in control databases in 4 of 169630 chromosomes at a frequency of 0.000024 increasing the likelihood that this may be a low frequency benign variant in certain populations of origin (Genome Aggregation Consortium Feb 27, 2017). The p.Pro294= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. |